The organic plant extracts of 21 species of Clusiaceae from Mexico were screened for anti HIV-1 reverse transcriptase activity in a non-radioactive immuno colorimetric assay. The extracts of 5 species (23.8%) exhibited significant inhibition (Ն70%) of HIV-1 RT activity; of these, only 4 extracts showed reduced toxicity to human lymphocytic MT2 cells and were further tested as inhibitors of HIV-1 IIIb/LAV replication in a cellular system. The best extracts were Calophyllum brasiliense (hexane) and Clusia quadrangula (CH 2 Cl 2 -MeOH) which inhibited HIV-1 RT (IC 50 ‫6.92؍‬ m mg/ml and 42 m mg/ml), and showed an EC 50 ‫5.29؍‬ m mg/ml and 91 m mg/ml, respectively, on MT2 cells. However, only Calophyllum brasiliense hexane extract showed significant inhibition on viral replication (ED 50 ‫1.73؍‬ m mg/ml), while Clusia quadrangula was less active (ED 50 ‫421؍‬ m mg/ml). These results support the idea that plant extracts represent a valuable source of potential anti HIV compounds.
HIV has been identified as the etiological agent of AIDS. 1, 2) The disease is characterized by opportunistic pathogen infections, accompanied by a drastic decrease in the number of CD4 T cells. It is now accepted that there are two types of HIV: HIV-1 and HIV-2. Most AIDS worldwide is caused by HIV-1.
3) The replicative cycle of HIV has been extensively studied to determine specific processes that can serve as drug targets. One of the most critical steps is the reverse transcription of viral RNA into a cDNA copy, which is catalyzed by enzyme reverse transcriptase (RT). 4) Many strategies have focused on the search for inhibitors against this viral enzyme; these compounds should also be non-toxic to uninfected cells. 5) However, in spite of the number and variety of anti-HIV drugs, the rapid development of HIV resistance necessitates continuation of the search for new drugs including synthetic and natural products. 6) In this context, highly active anti-retroviral therapy (HAART) has proved to be very beneficial to HIV infected patients, especially triple-drug combinations (3 RT inhibitors; 2 RT inhibitorsϩ1 protease inhibitors) over mono and bi-drug combinations. HAART has provided a sustained reduction of the plasma viral load, increased the CD4 T cells counts, and also delayed disease progression to AIDS. 7) However, these benefits are limited by important risks associated with prolonged use of this treatment, such as metabolic disturbances, cross pharmacological reactions with other drugs, and low adherence to long or permanent treatment; these could subsequently induce the rapid development of viral resistance, as well as deep toxicity effects recognized on the cardio-vascular system, liver, kidney, brain, pancreas and skin. 7, 8) For all these reasons and the fact that RT inhibitors are always used in triple-drug therapy, new substances with possible different toxic or resistant induction sites could offer alternative options in HIV RT therapeutics.
In the search for HIV-1 RT inhibitors, screening of plant extracts is a valuable method to discover new compounds potentially useful in therapeutics. 9, 10) Coumarins and benzophenones with these antiviral properties have been isolated from several plant species of the Clusiaceae family through bioguided fractionation. Among the most important coumarins able to inhibit HIV-1 RT with low cytotoxicity on uninfected cells are: (ϩ)-calanolide A, (Ϫ)-calanolide B, 11, 12) (ϩ) inophyllum B and P, 13, 14) soulattrolide; 15) (ϩ)-cordatolide A and (Ϫ)-cordatolide B.
16) All these substances were isolated from Calophyllum species. The most outstanding compound is (ϩ)-calanolide A, which showed potent and specific anti HIV-1 RT activity in in vitro as well as in in vivo pharmacological tests. [17] [18] [19] [20] This compound is currently in Phase I/II clinical trials. 21) In the case of benzophenones, guttiferone A isolated from Garcinia livingstonei, guttiferone E and isoxanthochymol isolated from Garcinia ovalifolia 22) showed anti HIV-1 RT activity in vitro, but their cytotoxic effects on human lymphocytic cell lines precluded further studies.
Since species from the Clusiaceae family represent a potential source of new chemical identities able to inhibit HIV-1 RT, 23) we have carried out a screening of Clusiaceae species that thrive in Mexico. In this study we report the evaluation of organic extracts of 21 species in their capacity for HIV-1 RT inhibition in vitro, their toxicity effects on human lymphocytes and their inhibition of HIV-1 replication in a cellular system.
MATERIALS AND METHODS

Plant Material
To establish which species should be included in this study, a preliminary taxonomic review was carried out with herbaria specimens. Clusiaceae samples were collected by us or obtained by donation from collectors or herbaria. Collections were performed in the states of Guerrero, Veracruz and Oaxaca in Mexico. Vouchers are deposited at the IMSS Medicinal Herbarium (IMSSM), National University of Mexico (MEXU), the Faculty of Sciences (FCME) and the Institute of Ecology (XAL). Taxonomical identity of each species was confirmed by one of the authors, Lucio Lozada.
Preparation of Extracts Plant material, preferably leaves, was dried at room temperature, powdered and extracted with CH 2 Cl 2 -MeOH (1 : 1). The extracts were evaporated to dryness. In the case of Calophyllum brasiliense, hexane, acetone and methanol extracts were also prepared. Biological Assays Antiviral activities of Clusiaceae extracts were evaluated by three successive assays. HIV-1 RT inhibition was first screened, and those extracts that showed inhibition over 70% were selected for the next bioassay. Cytotoxic effect of the extracts was examined on human lymphocyte cell lines. Non-toxic extracts were selected for the last bioassay, which consisted of determining inhibition of HIV-1 IIIb/LAV replication. Concentration-dependent activity of the most active extracts was performed in the three biological assays. Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) was used as positive control.
HIV-1 Inhibition by Extracts of Clusiaceae Species from Mexico
HIV-1 RT Inhibition HIV-1 RT inhibition by extracts was evaluated by a non-radioactive immuno and colorimetric assay (Lenti RT Activity Assay, Cavidi Tech). 24) Assay was performed according to the protocol provided by the manufacturer. Each extract was dissolved in dimethyl sulfoxide (DMSO) and tested at 50 mg/ml.
Toxic Effect on Human Lymphocytes Cell Line The cytotoxic effect of anti HIV-1 RT active extracts was determined on human lymphocytic MT2 cells. The assay was performed as follows: MT2 cells were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum, 0.25 mg/ml of streptomycin and 100 mg/ml of penicillin G, in the presence of the plant extracts. Culture was maintained at 37°C under 5% CO 2 humidified atmosphere. Plant extracts were dissolved in DMSO and tested at 50 mg/ml. After 48 h, cellular death was assessed by direct microscopic examination of trypan blue stained cells. Results were compared with a control of MT2 free of extract.
Inhibition of HIV-1 IIIb/LAV Replication Inhibition of viral replication by plant extracts was measured in a coculture of IIIb/LAV-Molt4 cells and non-infected MT2 cells in the presence of the plant extracts. Concentration of extracts and conditions of culture were the same as those described for the toxicity assay. After 48 h inhibition of viral replication was measured by a p24 antigen enzyme immunoassay (Genetic Systems HIV-1Ag EIA, Bio-Rad) performed in the culture supernatant.
RESULTS
Plant Material
Clusiaceae from Mexico was reviewed for the last time eighty years ago, 25) and 4 genera and 11 species were reported. Our taxonomic investigation in herbaria and in the field revealed that Clusiaceae in Mexico is now composed of 8 genera and 21 species (Table 1) . Extracts of all the species of Clusiaceae were prepared and tested at least in the HIV-1 RT screening assay. Although the species Marila laxiflora is present in Mexico, it was not possible to collect it and bioassays were performed with leaves of this species collected in Peru (South America).
HIV-1 RT Inhibition Extracts prepared from the leaves of 21 species of Clusiaceae were screened for anti-HIV-1 RT activity (Table 1) . Five species (23.8%) showed a high anti HIV-1 RT (Ն70% inhibition), while 7 species (33.3%) were moderately active (50 to 70% inhibition) and 9 species showed less than 50% inhibition ( Table 1 ). The three most active extracts belong to the same species, Calophyllum brasiliense: hexane (77.9%), acetone (81.3%) and methanol (83.3%). Extracts of Clusia massoniana and Vismia mexicana produced a 72.9% inhibition of the enzyme, while Clusia guatemalensis and Vismia camparaguey showed 70.8% inhibition. The anti-HIV-1 RT activity of extracts from other plant organs is also shown in Table 1 . In this case, the highest inhibitory activity found was 64.1% inhibition for the flower extract of Marila laxiflora.
Toxic Effect on Human Lymphocytes Cell Line The lymphocyte toxicity assay was performed only with the most active extracts (Ն70%) and C. quadrangula. Only five of the nine selected extracts were non-toxic to lymphocytes MT2: Calophyllum brasiliense (hexane, methanol and CH 2 Cl 2 -MeOH), Vismia mexicana and Clusia quadrangula (Fig. 1) . Non-toxicity criteria were established based on no difference in cell number between control and treatment (ANOVA pϽ0.05).
Inhibition of HIV-1 IIIb/LAV Replication The hexane extract of Calophyllum brasiliense inhibited HIV-1 IIIb/LAV replication in 74.5%, while the methanol extract of Calophyllum brasiliense, Vismia mexicana and Clusia quadrangula extracts exhibited less than 52% inhibition (Fig. 2) .
Concentration-Dependent Effects
Since Calophyllum brasiliense hexane extract was the best in the 3 biological assays, its concentration-dependent effects were determined. The range of concentrations tested was 10-120 mg/ml. The HIV-1 RT IC 50 was 29.6 mg/ml, while ED 50 for HIV-1 IIIb/LAV replication was 37.1 mg/ml. EC 50 on MT2 cells was observed at 92.5 mg/ml. For comparison with C. brasiliense hexane extract, concentration-dependent assay was also performed for Clusia quadrangula extract. The IC 50 (42 mg/ml) and EC 50 (91 mg/ml) were similar to Calophyllum brasiliense hexane extract, but ED 50 was 3 times lower (ED 50 ϭ 124 mg/ml) (Fig. 3) . Nevirapine control showed EC 50 ϭ Ͼ200 mM and ED 50 ϭ0.03 mM; these values were very similar to those reported in the literature for this compound with MT4 cells and HIV-1 IIIb. 26) DISCUSSION A number of anti HIV-1 plant extract screenings have been performed during the last years and several active plants and secondary metabolites have been recognized, most of them able to act specifically on enzymatic targets. 27, 28) Nevertheless, none of these substances is completely innocuous. 29) Therefore, evaluation of cytotoxicity is necessary towards the development of effective anti-HIV drugs. Several screenings include HIV-1 RT inhibition and cytotoxicity, but few also involve inhibition of viral replication in cellular systems. 30, 31) This study offers an evaluation of these three parameters for selected extracts.
The present screening comprised the 8 genera and 21 species belonging to Clusiaceae that thrive in Mexico. Twelve species (57.1%) showed high to moderate anti HIV-1 RT activity, supporting the idea of Clusiaceae as a valuable source of HIV inhibitory natural product leads. 23) In this study Calophyllum brasiliense hexane extract showed the best performance in the three bioassays. Another interesting extract, Clusia quadrangula overcame the two former tests. Thus we performed concentration-response experiments with both extracts and contrasted them with published data (Fig. 3) .
Regarding the HIV-1 RT inhibitory properties of plant extracts, some authors have pointed out that an IC 50 Յ50 mg/ml is considered significant. 28, 31) Therefore, Calophyllum brasiliense hexane extract (IC 50 ϭ29.6 mg/ml) and Clusia quadrangula (IC 50 ϭ42 mg/ml) can be included in this category (Fig. 3A) . In relation to inhibition of HIV-1 replication in cellular systems by extracts, it was reported that Crinum asiaticum var. japonicum (Amaryllidaceae) showed significant anti HIV-1 activity (ED 50 ϭ12.5 mg/ml). 31) Our data show that Calophyllum brasiliense hexane extract required an ED 50 ϭ37.1 mg/ml, that still can be considered as significant. In contrast, Clusia quadrangula required a concentration almost 10 times higher (ED 50 ϭ124 mg/ml). Concerning cytotoxicity, it has been indicated that an EC 50 Ͼ200 mg/ml is a low cytotoxic profile. 31) In our study, Calophyllum brasiliense hexane extract and Clusia quadrangula have an EC 50 ϭ92.5 mg/ml and 91 mg/ml, respectively; in consequence, their performance in this parameter was poor (Fig.  3B) .
Our data suggest that Calophyllum brasiliense hexane extract possesses anti-HIV activities. Curiously, this species was omitted in previous studies of the evaluation of anti HIV properties by McKee et al. 32) These authors performed a chemotaxonomic study of Calophyllum species, mainly collected in Malaysia, in order to search for dipyranocoumarins with HIV-1 RT inhibitory properties. Their method included a TLC test for detecting dipyranocoumarins by a characteristic deep blue spot, using (Ϫ)-calanolide B and soulattrolide as standards, and positive extracts were further fractionated. Calophyllum brasiliense was not included as a candidate because of the absence of dipyranocoumarins on TLC. We recently detected the existence of two chemotypes of Calophyllum brasiliense in Mexico. The first one is included in this study and showed high inhibitory value for hexane, acetone and methanol extracts in HIV-1 RT assay, suggesting that they may contain HIV-1 inhibitory substances. Bioguided fractionation of these extracts is currently in progress to determine the active constituents. The second chemotype contains mammea type coumarins, all of them inactive against HIV-1 RT, and these will be reported in an independent paper at a later date. 
